Ionis Pharmaceuticals (IONS) Current Assets (2009 - 2026)

Ionis Pharmaceuticals has reported Current Assets for 18 years, with the latest figure at $2.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 21.41% year-over-year to $2.9 billion; the trailing twelve-month figure through Mar 2026 stood at $2.9 billion (up 21.41% YoY), and the FY2025 full-year result was $3.0 billion, up 14.13% from the prior year.
• Current Assets for Q1 2026 stood at $2.9 billion, down from $3.0 billion in the prior quarter.
• The five-year high for Current Assets was $3.0 billion in Q4 2025, with the low at $2.2 billion in Q3 2022.
• Average Current Assets over 5 years is $2.5 billion, with a median of $2.5 billion recorded in 2023.
• Year-over-year, Current Assets dropped 10.98% in 2024 and gained 21.41% in 2026.
• Tracing IONS's Current Assets over 5 years: stood at $2.2 billion in 2022, then grew by 19.94% to $2.6 billion in 2023, then dropped by 0.82% to $2.6 billion in 2024, then climbed by 14.13% to $3.0 billion in 2025, then fell by 1.8% to $2.9 billion in 2026.
• The last three Current Assets figures came in at $2.9 billion (Q1 2026), $3.0 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.

Peer Comparison